Murali Mohan Yallapu

University Of Tennessee Health Sci Ctr

$4,124,987

Attributed

$4,124,987

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.5M · FY2015–25

$2M$1.5M$1M$500K$0

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$4,124,987 · 3

By mechanism

U54$2,186,922 · 1

SC1$1,453,000 · 1

K22$485,065 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsTheranosticsTrainingMagnetic Resonance ImagingChemotherapyToxic EffectResistanceProstate Cancer CellNanoparticleMouse ModelMagnetic NanoparticlesMalignant Neoplasm Of ProstateNeoplasm MetastasisMediatingProstate Cancer Cell LineDocetaxelBiological AvailabilityProstateCharacteristicsCancer CellAntigen TargetingGrowthTargeted TreatmentTreatment Efficacy